LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 24.73 | 17.25 | 1652 | 1290 | 1.2804 | 1.0810 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 26.70 | 17.25 | 695 | 1466 | 0.4739 | 0.7800 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 26.70 | 17.25 | 1780 | 1466 | 1.2136 | 1.0613 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 26.70 | 17.25 | 499 | 1466 | 0.3402 | 0.6904 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 26.70 | 17.25 | 1767 | 1466 | 1.2047 | 1.0590 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 28.67 | 17.25 | 826 | 1653 | 0.4997 | 0.7999 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 28.67 | 17.25 | 1961 | 1653 | 1.1862 | 1.0526 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 28.67 | 17.25 | 710 | 1653 | 0.4295 | 0.7590 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 28.67 | 17.25 | 1958 | 1653 | 1.1844 | 1.0521 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 30.64 | 17.25 | 1071 | 1887 | 0.5674 | 0.8395 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 30.64 | 17.25 | 2171 | 1887 | 1.1502 | 1.0418 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 30.64 | 17.25 | 913 | 1887 | 0.4837 | 0.7967 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 30.64 | 17.25 | 2221 | 1887 | 1.1767 | 1.0486 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 32.61 | 17.25 | 1427 | 2136 | 0.6680 | 0.8872 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 32.61 | 17.25 | 2469 | 2136 | 1.1557 | 1.0421 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 32.61 | 17.25 | 1109 | 2136 | 0.5191 | 0.8200 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 32.61 | 17.25 | 2462 | 2136 | 1.1524 | 1.0412 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 34.57 | 17.25 | 1997 | 2523 | 0.7915 | 0.9360 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 34.57 | 17.25 | 2732 | 2523 | 1.0828 | 1.0222 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 34.57 | 17.25 | 1741 | 2523 | 0.6900 | 0.8994 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 34.57 | 17.25 | 2669 | 2523 | 1.0578 | 1.0157 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 36.54 | 17.25 | 2335 | 2679 | 0.8713 | 0.9625 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 36.54 | 17.25 | 2918 | 2679 | 1.0889 | 1.0235 | MN20160310_N02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 36.54 | 17.25 | 2033 | 2679 | 0.7586 | 0.9255 | MN20160310_N02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 36.54 | 17.25 | 2909 | 2679 | 1.0855 | 1.0227 | MN20160310_N02 | H08 |